CYRX - Cryoport, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
3/30/2016
Total Revenue
30,391
19,626
11,954
7,679
5,882
Cost of Revenue
15,155
9,386
5,988
4,577
3,992
Gross Profit
15,236
10,240
5,966
3,101
1,890
Operating Expenses
Research Development
3,270
1,840
1,206
598
550
Selling General and Administrative
30,982
17,044
12,653
11,269
10,081
Total Operating Expenses
34,252
18,885
13,859
11,868
10,631
Operating Income or Loss
-19,017
-8,645
-7,893
-8,766
-8,741
Interest Expense
990
69
16
139
1,066
Total Other Income/Expenses Net
379
-822
14
-4,202
-10
Income Before Tax
-19,627
-9,536
-7,894
-13,108
-9,817
Income Tax Expense
15
20
5
6
4
Income from Continuing Operations
-19,642
-9,556
-7,899
-13,113
-9,820
Net Income
-19,642
-9,556
-7,899
-13,113
-9,820
Net Income available to common shareholders
-19,642
-9,556
-7,899
-13,189
-15,057
Reported EPS
Basic
-
-0.34
-0.34
-0.93
-1.91
Diluted
-
-0.34
-0.34
-0.93
-1.91
Weighted average shares outstanding
Basic
-
28,211
22,963
14,221
7,867
Diluted
-
28,211
22,963
14,221
7,867
EBITDA
-
-8,608
-7,213
-12,594
-8,512